｜ Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B
- VernacularTitle:｜恩替卡韦联合复方鳖甲软肝片可进一步降低慢性乙型肝炎患者肝细胞癌的风险
- Publication Type:Introduction of High-quality Articles in Foreign Journals
- From: Journal of Clinical Hepatology 2023;39(1):151-151
- CountryChina
- Language:Chinese